Clinical Trial Update: Benign/Malignant Pulmonary Nodule Classification Based on High-throughput Whole-genome Methylation Sequencing(GM-seq)

View source ↗

Summary

A completed clinical trial evaluated using high-throughput whole-genome methylation sequencing to classify solitary pulmonary nodules as benign or malignant.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solitary Pulmonary Nodule

Snippet

Sponsor: Geneplus-Beijing Co. Ltd. | Conditions: Pulmonary Nodule, Solitary, Whole-genome Methylation Sequencing | Status: COMPLETED